Notably, almost no methylation was observed in several CpG sites of the CCND2 promoter regions of adjacent normal tissues in all types of cancer, but hypermethylation was observed in breast cancer and lung adenocarcinoma. This evidence concerns the gene CCND2 and lung adenocarcinoma.